$11.64
+0.25 (+2.19%)
As of May 9, 1:29 AM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +584.3% upside
Low Target $56.38
Average Target $79.65
High Target $102.54
Current Price $11.64
Current
$11.64
Target
$79.65
$56.38 $79.65 avg $102.54
Scenario Analysis
Bear Case
$56.38
384.4%
Low target
Base Case
$79.65
+584.3%
Avg target
Bull Case
$102.54
+780.9%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$28.44
-59.1% from high
52-Week Low
$9.23
+26.2% from low
50-Day SMA
$14.19
-18.0% vs SMA
200-Day SMA
$20.75
-43.9% vs SMA
RSI (14)
65.7
Neutral
Target vs 52W High
$79.65
+180.1% vs high
Next Earnings Report
May 12, 2026
2d
until earnings
EPS Est: $0.34
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%